1. Home
  2. TDOC vs IOVA Comparison

TDOC vs IOVA Comparison

Compare TDOC & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teladoc Health Inc.

TDOC

Teladoc Health Inc.

HOLD

Current Price

$9.14

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$4.20

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TDOC
IOVA
Founded
2002
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2015
2008

Fundamental Metrics

Financial Performance
Metric
TDOC
IOVA
Price
$9.14
$4.20
Analyst Decision
Buy
Buy
Analyst Count
18
10
Target Price
$7.56
$9.00
AVG Volume (30 Days)
4.2M
14.1M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
80.58
14.84
EPS
N/A
N/A
Revenue
$2,406,840,000.00
N/A
Revenue This Year
$1.19
$47.74
Revenue Next Year
$1.25
$40.31
P/E Ratio
N/A
N/A
Revenue Growth
18.41
N/A
52 Week Low
$4.40
$1.70
52 Week High
$9.77
$5.63

Technical Indicators

Market Signals
Indicator
TDOC
IOVA
Relative Strength Index (RSI) 72.40 56.87
Support Level $6.62 $2.07
Resistance Level $9.70 $4.35
Average True Range (ATR) 0.43 0.33
MACD 0.13 -0.00
Stochastic Oscillator 98.84 55.29

Price Performance

Historical Comparison
TDOC
IOVA

About TDOC Teladoc Health Inc.

Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: